ClinicalTrials.gov
ClinicalTrials.gov Menu

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00827359
Recruitment Status : Active, not recruiting
First Posted : January 22, 2009
Last Update Posted : June 29, 2017
Sponsor:
Collaborators:
Duke University
Novartis
Information provided by (Responsible Party):
David F. McDermott, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : June 2018